Guidance for laboratories performing molecular pathology for cancer patients

Ian A. Cree, Ian A. Cree, Zandra Deans, Marjolijn J L Ligtenberg, Patricia Groenen, J. Han Van Krieken, Nicola Normanno, Anders Edsjö, Etienne Rouleau, Francesc Solé, Erik Thunnissen, Wim Timens, Ed Schuuring, Elisabeth Dequeker, Samuel Murray, Manfred Dietel

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

Molecular testing is becoming an important part of the diagnosis of any patient with cancer. The challenge to laboratories is to meet this need, using reliable methods and processes to ensure that patients receive a timely and accurate report on which their treatment will be based. The aim of this paper is to provide minimum requirements for the management of molecular pathology laboratories. This general guidance should be augmented by the specific guidance available for different tumour types and tests. Preanalytical considerations are important, and careful consideration of the way in which specimens are obtained and reach the laboratory is necessary. Sample receipt and handling follow standard operating procedures, but some alterations may be necessary if molecular testing is to be performed, for instance to control tissue fixation. DNA and RNA extraction can be standardised and should be checked for quality and quantity of output on a regular basis. The choice of analytical method(s) depends on clinical requirements, desired turnaround time, and expertise available. Internal quality control, regular internal audit of the whole testing process, laboratory accreditation, and continual participation in external quality assessment schemes are prerequisites for delivery of a reliable service. A molecular pathology report should accurately convey the information the clinician needs to treat the patient with sufficient information to allow for correct interpretation of the result. Molecular pathology is developing rapidly, and further detailed evidence-based recommendations are required for many of the topics covered here.

Original languageEnglish
Pages (from-to)923-931
Number of pages9
JournalJournal of Clinical Pathology
Volume67
Issue number11
DOIs
Publication statusPublished - Nov 1 2014

Fingerprint

Molecular Pathology
Neoplasms
Tissue Fixation
Accreditation
Quality Control
RNA
DNA
Therapeutics

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medicine(all)

Cite this

Cree, I. A., Cree, I. A., Deans, Z., Ligtenberg, M. J. L., Groenen, P., Van Krieken, J. H., ... Dietel, M. (2014). Guidance for laboratories performing molecular pathology for cancer patients. Journal of Clinical Pathology, 67(11), 923-931. https://doi.org/10.1136/jclinpath-2014-202404

Guidance for laboratories performing molecular pathology for cancer patients. / Cree, Ian A.; Cree, Ian A.; Deans, Zandra; Ligtenberg, Marjolijn J L; Groenen, Patricia; Van Krieken, J. Han; Normanno, Nicola; Edsjö, Anders; Rouleau, Etienne; Solé, Francesc; Thunnissen, Erik; Timens, Wim; Schuuring, Ed; Dequeker, Elisabeth; Murray, Samuel; Dietel, Manfred.

In: Journal of Clinical Pathology, Vol. 67, No. 11, 01.11.2014, p. 923-931.

Research output: Contribution to journalArticle

Cree, IA, Cree, IA, Deans, Z, Ligtenberg, MJL, Groenen, P, Van Krieken, JH, Normanno, N, Edsjö, A, Rouleau, E, Solé, F, Thunnissen, E, Timens, W, Schuuring, E, Dequeker, E, Murray, S & Dietel, M 2014, 'Guidance for laboratories performing molecular pathology for cancer patients', Journal of Clinical Pathology, vol. 67, no. 11, pp. 923-931. https://doi.org/10.1136/jclinpath-2014-202404
Cree IA, Cree IA, Deans Z, Ligtenberg MJL, Groenen P, Van Krieken JH et al. Guidance for laboratories performing molecular pathology for cancer patients. Journal of Clinical Pathology. 2014 Nov 1;67(11):923-931. https://doi.org/10.1136/jclinpath-2014-202404
Cree, Ian A. ; Cree, Ian A. ; Deans, Zandra ; Ligtenberg, Marjolijn J L ; Groenen, Patricia ; Van Krieken, J. Han ; Normanno, Nicola ; Edsjö, Anders ; Rouleau, Etienne ; Solé, Francesc ; Thunnissen, Erik ; Timens, Wim ; Schuuring, Ed ; Dequeker, Elisabeth ; Murray, Samuel ; Dietel, Manfred. / Guidance for laboratories performing molecular pathology for cancer patients. In: Journal of Clinical Pathology. 2014 ; Vol. 67, No. 11. pp. 923-931.
@article{c33f440e516a45de9386e074a60b5b7f,
title = "Guidance for laboratories performing molecular pathology for cancer patients",
abstract = "Molecular testing is becoming an important part of the diagnosis of any patient with cancer. The challenge to laboratories is to meet this need, using reliable methods and processes to ensure that patients receive a timely and accurate report on which their treatment will be based. The aim of this paper is to provide minimum requirements for the management of molecular pathology laboratories. This general guidance should be augmented by the specific guidance available for different tumour types and tests. Preanalytical considerations are important, and careful consideration of the way in which specimens are obtained and reach the laboratory is necessary. Sample receipt and handling follow standard operating procedures, but some alterations may be necessary if molecular testing is to be performed, for instance to control tissue fixation. DNA and RNA extraction can be standardised and should be checked for quality and quantity of output on a regular basis. The choice of analytical method(s) depends on clinical requirements, desired turnaround time, and expertise available. Internal quality control, regular internal audit of the whole testing process, laboratory accreditation, and continual participation in external quality assessment schemes are prerequisites for delivery of a reliable service. A molecular pathology report should accurately convey the information the clinician needs to treat the patient with sufficient information to allow for correct interpretation of the result. Molecular pathology is developing rapidly, and further detailed evidence-based recommendations are required for many of the topics covered here.",
author = "Cree, {Ian A.} and Cree, {Ian A.} and Zandra Deans and Ligtenberg, {Marjolijn J L} and Patricia Groenen and {Van Krieken}, {J. Han} and Nicola Normanno and Anders Edsj{\"o} and Etienne Rouleau and Francesc Sol{\'e} and Erik Thunnissen and Wim Timens and Ed Schuuring and Elisabeth Dequeker and Samuel Murray and Manfred Dietel",
year = "2014",
month = "11",
day = "1",
doi = "10.1136/jclinpath-2014-202404",
language = "English",
volume = "67",
pages = "923--931",
journal = "Journal of Clinical Pathology - Clinical Molecular Pathology",
issn = "0021-9746",
publisher = "BMJ Publishing Group",
number = "11",

}

TY - JOUR

T1 - Guidance for laboratories performing molecular pathology for cancer patients

AU - Cree, Ian A.

AU - Cree, Ian A.

AU - Deans, Zandra

AU - Ligtenberg, Marjolijn J L

AU - Groenen, Patricia

AU - Van Krieken, J. Han

AU - Normanno, Nicola

AU - Edsjö, Anders

AU - Rouleau, Etienne

AU - Solé, Francesc

AU - Thunnissen, Erik

AU - Timens, Wim

AU - Schuuring, Ed

AU - Dequeker, Elisabeth

AU - Murray, Samuel

AU - Dietel, Manfred

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Molecular testing is becoming an important part of the diagnosis of any patient with cancer. The challenge to laboratories is to meet this need, using reliable methods and processes to ensure that patients receive a timely and accurate report on which their treatment will be based. The aim of this paper is to provide minimum requirements for the management of molecular pathology laboratories. This general guidance should be augmented by the specific guidance available for different tumour types and tests. Preanalytical considerations are important, and careful consideration of the way in which specimens are obtained and reach the laboratory is necessary. Sample receipt and handling follow standard operating procedures, but some alterations may be necessary if molecular testing is to be performed, for instance to control tissue fixation. DNA and RNA extraction can be standardised and should be checked for quality and quantity of output on a regular basis. The choice of analytical method(s) depends on clinical requirements, desired turnaround time, and expertise available. Internal quality control, regular internal audit of the whole testing process, laboratory accreditation, and continual participation in external quality assessment schemes are prerequisites for delivery of a reliable service. A molecular pathology report should accurately convey the information the clinician needs to treat the patient with sufficient information to allow for correct interpretation of the result. Molecular pathology is developing rapidly, and further detailed evidence-based recommendations are required for many of the topics covered here.

AB - Molecular testing is becoming an important part of the diagnosis of any patient with cancer. The challenge to laboratories is to meet this need, using reliable methods and processes to ensure that patients receive a timely and accurate report on which their treatment will be based. The aim of this paper is to provide minimum requirements for the management of molecular pathology laboratories. This general guidance should be augmented by the specific guidance available for different tumour types and tests. Preanalytical considerations are important, and careful consideration of the way in which specimens are obtained and reach the laboratory is necessary. Sample receipt and handling follow standard operating procedures, but some alterations may be necessary if molecular testing is to be performed, for instance to control tissue fixation. DNA and RNA extraction can be standardised and should be checked for quality and quantity of output on a regular basis. The choice of analytical method(s) depends on clinical requirements, desired turnaround time, and expertise available. Internal quality control, regular internal audit of the whole testing process, laboratory accreditation, and continual participation in external quality assessment schemes are prerequisites for delivery of a reliable service. A molecular pathology report should accurately convey the information the clinician needs to treat the patient with sufficient information to allow for correct interpretation of the result. Molecular pathology is developing rapidly, and further detailed evidence-based recommendations are required for many of the topics covered here.

UR - http://www.scopus.com/inward/record.url?scp=84908491991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908491991&partnerID=8YFLogxK

U2 - 10.1136/jclinpath-2014-202404

DO - 10.1136/jclinpath-2014-202404

M3 - Article

C2 - 25012948

AN - SCOPUS:84908491991

VL - 67

SP - 923

EP - 931

JO - Journal of Clinical Pathology - Clinical Molecular Pathology

JF - Journal of Clinical Pathology - Clinical Molecular Pathology

SN - 0021-9746

IS - 11

ER -